Midline vs. Paramedian Approaches for US-assisted Spinal Anesthesia
Midline Versus Paramedian Approaches for Ultrasound-assisted Spinal Anesthesia: a Randomized Controlled Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Seoul, Korea, Republic of, 03080
- Seoul National University Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult patients scheduled to undergoing elective orthopedic surgery under spinal anesthesia, with ASA physical status classification I, II, III
Exclusion Criteria:
- Patients with contraindication to spinal anesthesia (coagulopathy, local infection, allergy to local anesthetic)
- Patients with morbid cardiac diseases
- Pregnancy
- Patients with previous history of lumbar spinal surgery
- Patients with anatomical abnormality of lumbar spine
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
EXPERIMENTAL: Midline group
Preprocedural ultrasound-assisted midline approach of spinal anesthesia will be performed.
0.5% heavy bupivacaine will be injected to intrathecal space for spinal anesthesia.
|
A preprocedural ultrasound scanning will be done, and skin marking will be made.
The needle entry point and insertion angle will be determined based on ultrasound scanning.
Spinal anesthesia will be performed via midline approach.
|
|
ACTIVE_COMPARATOR: Paramedian group
Preprocedural ultrasound-assisted paramedian approach of spinal anesthesia will be performed.
0.5% heavy bupivacaine will be injected to intrathecal space for spinal anesthesia.
|
A preprocedural ultrasound scanning will be done, and skin marking will be made.
The needle entry point and insertion angle will be determined based on ultrasound scanning.
Spinal anesthesia will be performed via paramedian approach.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the number of needle passes
Time Frame: Intraoperative (from the first insertion of needle to patient's skin, until the completion of spinal anesthetic injection)
|
the number of forward advancements of the spinal needle in a given interspinous space, i.e., withdrawal and redirection of spinal needle without exiting the skin
|
Intraoperative (from the first insertion of needle to patient's skin, until the completion of spinal anesthetic injection)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of spinal needle insertion attempts
Time Frame: Intraoperative (from the first insertion of needle to patient's skin, until the completion of spinal anesthetic injection)
|
the number of times the spinal needle was withdrawn from the skin and reinserted
|
Intraoperative (from the first insertion of needle to patient's skin, until the completion of spinal anesthetic injection)
|
|
Time taken for performing spinal anesthetic
Time Frame: Intraoperative (from insertion of the needle to the completion of injection)
|
time from needle insertion to the completion of injection
|
Intraoperative (from insertion of the needle to the completion of injection)
|
|
Incidence of radicular pain, paraesthesia, and blood tapping in the spinal needle
Time Frame: Intraoperative (from the first insertion of needle, until the completion of spinal anesthetic injection)
|
Incidence of radicular pain, paraesthesia, and blood tapping in the spinal needle during the spinal anesthesia procedure
|
Intraoperative (from the first insertion of needle, until the completion of spinal anesthetic injection)
|
|
Periprocedural pain
Time Frame: Patients will be asked immediately after the completion of spinal anesthesia
|
11-point verbal rating scale (0=no pain, 10=most pain imaginable)
|
Patients will be asked immediately after the completion of spinal anesthesia
|
|
Periprocedural discomfort score
Time Frame: Patients will be asked immediately after the completion of spinal anesthesia
|
11-point verbal rating scale (0=no discomfort, 10=most discomfort imaginable)
|
Patients will be asked immediately after the completion of spinal anesthesia
|
|
Time for identifying landmarks
Time Frame: intraoperative (time taken for establish the landmark, from start of US scanning to completion of scanning
|
time from placement of the ultrasound probe on the skin to the completion of markings.
|
intraoperative (time taken for establish the landmark, from start of US scanning to completion of scanning
|
|
dermatome level of sensory block
Time Frame: 20 minutes after the completion of spinal anesthetic injection
|
thoracic dermatome level of sensory block assessed by loss of cold sensation tested with 2% chlorhexidine swab
|
20 minutes after the completion of spinal anesthetic injection
|
|
Patient satisfaction score of spinal anesthesia procedure
Time Frame: Patients will be asked immediately after the completion of spinal anesthesia
|
11-point verbal rating scale (0=very unsatisfied, 10=very satisfied)
|
Patients will be asked immediately after the completion of spinal anesthesia
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
General Publications
- Kallidaikurichi Srinivasan K, Iohom G, Loughnane F, Lee PJ. Conventional Landmark-Guided Midline Versus Preprocedure Ultrasound-Guided Paramedian Techniques in Spinal Anesthesia. Anesth Analg. 2015 Oct;121(4):1089-1096. doi: 10.1213/ANE.0000000000000911.
- Park SK, Cheun H, Kim YW, Bae J, Yoo S, Kim WH, Lim YJ, Kim JT. Ultrasound-assisted spinal anesthesia: A randomized comparison between midline and paramedian approaches. J Clin Anesth. 2022 Sep;80:110823. doi: 10.1016/j.jclinane.2022.110823. Epub 2022 Apr 11.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- H-1803-060-928
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.